PPD is a chronic condition characterised by reddish-brown skin lesions caused by capillaritis. Although it can arise on any part of the body, lesions are usually found on the legs. While benign, PPD can cause considerable cosmetic concern. There is no effective treatment available for PPD, which calls for new therapies to be explored. The use of 10% TGA gel was found to be effective for pigmentary dermatoses in general. Thus, Dr Arunima Ray (IMS and SUM Hospital, India) and her team conducted a pilot study to assess the efficacy and safety of 10% TGA in the clearance of PPD [1].
A prospective, right-left leg comparative pilot study was conducted in patients with bilateral PPD over the legs. Peeling sessions were done in a tertiary hospital in Eastern India. The peel was applied weekly on the left leg for 6 weeks, while the right leg remained untreated. Photographs and dermoscopic images were evaluated at baseline and weeks 3 and 6. Patient self-assessment and dermatologists’ assessment were compared. Side effects were monitored during the peel application and afterwards.
Of 10 patients included, 4 observed mild improvement, 5 moderate improvement, and 1 marked improvement. According to the physician’s assessment, 2 patients had >60% improvement, 5 patients had 30–60% improvement, and 3 patients had <30% improvement. Dermoscopic assessment showed a decrease in red dots and intensity of brownish pigment at 6 weeks in all patients. An increase in scaling was seen in the post-peel period in all patients. Side effects were mild, including burning sensation, foul smell, and persistent smell during peel application. One patient had post-procedural erythema, pain, and swelling of the peeling site for 5 days, which was resolved with topical mometasone.
In conclusion, 10% TGA was effective in the partial clearance of PPD dyspigmentation with weekly sessions for 6 weeks without any serious side effects. While TGA peel is commercially unavailable in India, topical TGA can be safely used at less than 15% concentration.
- Ray A, et al. Use of 10% thioglycolic acid peel in treatment of pigmented purpuric dermatoses – a pilot study. Abstract 220, ICD 2021, 10–13 November.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Benefits of microneedling with platelet-rich plasma for acne scars Next Article
Ceramides and their role in skincare »
« Benefits of microneedling with platelet-rich plasma for acne scars Next Article
Ceramides and their role in skincare »
Table of Contents: ICD 2021
Featured articles
Autologous serum therapy benefits chronic spontaneous urticaria
ICD Round-Up Articles
An unusual case of E. coli cellulitis in an immunocompetent patient
Autologous serum therapy benefits chronic spontaneous urticaria
Comparing routes of administration of methotrexate in psoriasis patients
Expanding the toolbox: what is new in melanoma detection?
Equity in dermatology: Skin Care For All
Challenges in diagnosis and treatment of leprosy in Brazil
A PASSION to provide dermatological care in LMICs
Paediatric dermatology in Tunisia: common diagnoses
Registry of vitiligo patients aims to break the stigma
10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis
Benefits of microneedling with platelet-rich plasma for acne scars
Related Articles
December 2, 2021
An unusual case of E. coli cellulitis in an immunocompetent patient
December 2, 2021
Autologous serum therapy benefits chronic spontaneous urticaria
December 2, 2021
Paediatric dermatology in Tunisia: common diagnoses
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy